IVF (INVO Fertility) Quality Rank


IVF INVO Fertility Inc IVF
35 GF Score
Price $1.13
GF Value $134.71
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is INVO Fertility Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

INVO Fertility Quality Rank Related Terms

IVF
35GF Score
INVO Fertility Inc IVF
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is INVO Fertility (IVF) Overvalued in 2026?

Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued. The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71. GuruFocus considers INVO Fertility to be Possible Value Trap.

Key valuation signals for IVF:

  • Quality Rank:
  • GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INVO Fertility Business Description

Address 5582 Broadcast Court, Sarasota, FL, USA, 34240
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score

Get the complete analysis for IVF

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price
$134.71
GF Value